Acabrunat 100 mg (Acalabrutinib)

Acabrunat 100 mg (Acalabrutinib) is an oral targeted therapy used in certain blood cancers like chronic lymphocytic leukemia (CLL). It works by blocking signals that abnormal B-cells need to grow and survive, helping to slow disease progression over time. It is usually taken as advised by a doctor, with or without food. Some people may experience headaches, tiredness, or mild infections. Always follow medical guidance. Active Ingredient (Generic Name): Acalabrutinib Indication: Blood Cancer Manufacturer: Natco Pharma Ltd. Packaging: 30 capsules in 1 bottle Strength 100mg Delivery Time: 6 To 15 days